Previous 10 | Next 10 |
FT. MYERS, FL / ACCESSWIRE / October 13, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to release its third quarter 2021, financial results on Thursday, November 4, 2021. The C...
Shares of healthcare company Guardant Health (NASDAQ: GH) are down 14.2% as of mid-session today on the heels of unconfirmed reports that it's interested in acquiring peer and indirect rival NeoGenomics (NASDAQ: NEO) . Only citing "people familiar with the matter," Bloom...
NeoGenomics has been plagued by profitability headwinds that have inflected directly to its share price in the last 2 years. Its intention to become a "one-stop oncology shop" is well received, although the company has yet to convert on this just yet. Shares are richly valued rela...
FT MYERS, FL / ACCESSWIRE / September 9, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that its liquid biopsy focused subsidiary Inivata Limited ("Inivata") alongside collab...
FT. MYERS, FL / ACCESSWIRE / September 1, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that Mark Mallon, Chief Executive Officer, Kathryn McKenzie, Chief Financial Officer,...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Covid-19 Goes Endemic. Is Your Portfolio Ready? When the coronavirus pandemic first hit the U.S. in 2020, I found myself at Home Depot (NYSE: HD ) shopping for makeshift gym equipment. The mad rush for stay-at-home ...
Image source: The Motley Fool. NeoGenomics, inc (NASDAQ: NEO) Q2 2021 Earnings Call Aug 6, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: NeoGenomics, inc (NEO) Q2 2021 Earnings Call Transcript
NeoGenomics, Inc. (NEO) Q2 2021 Earnings Conference Call August 06, 2021, 08:30 AM ET Company Participants Doug VanOort - Chairman Mark Mallon - CEO Kathryn McKenzie - CFO George Cardoza - President, Pharma Services Division Bill Bonello - President, Informatics Division Doug Brown - Chief St...
NeoGenomics (NASDAQ:NEO): Q2 Non-GAAP EPS of -$0.01 beats by $0.05; GAAP EPS of $0.59 beats by $0.70. Revenue of $121.72M (+39.9% Y/Y) beats by $3.59M. The Company reiterated its full-year 2021 guidance. Revenue: $490M - $510M (consensus $500.08M); net loss: $(70M) - $(65M); Adjusted EBI...
Second-Quarter 2021 Results and Highlights: Consolidated revenue increased 40% to $122 million Clinical Services revenue increased 37% to $101 million Pharma Services revenue increased 55% to $20 million Completed the acquisitions of Trapelo Health in April and Inivata Limited ...
News, Short Squeeze, Breakout and More Instantly...
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that it will report its second quarter 2024 financial results after the close of the U.S. financial markets on Monday, July 29, 2024. Company management will host a webcast and conference call at 4:30 ...
2024-06-23 10:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that Fort Myers’ Mayor, Kevin Anderson, will be dedicating June as NeoGenomics’ Commitment to Cancer Month to honor cancer survivors and those currently living with cancer. Headquartered in...